0QGJ fundamentals
An in-depth look to MEDIGENE AG NPV operating, investing, and financing activities
0QGJ free cash flow for H2 23 is -7.4 M EUR. For 2023, 0QGJ free cash flow was -15.78 M EUR and operating cash flow was -15.12 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM